Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism.
Open Access
- 11 May 1998
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 158 (9) , 1005-1010
- https://doi.org/10.1001/archinte.158.9.1005
Abstract
EVIDENCE-BASED guidelines for the treatment of deep venous thrombosis currently recommend at least 5 days of intravenous heparin overlapping with at least 4 or 5 days of warfarin sodium or until the international normalized ratio (INR) is 2.0 or more.1 However, in the 1990s health care systems are moving rapidly to reduce health care expenditures, particularly the cost of hospital care. For patients with symptomatic deep venous thrombosis this means shortening the length of hospital stay by instituting oral anticoagulant therapy on the day of admission and discontinuing heparin as soon as a therapeutic INR is achieved. However, there are no published data regarding the efficacy of intravenous heparin therapy for fewer than 5 days.This publication has 10 references indexed in Scilit:
- The Long-Term Clinical Course of Acute Deep Venous ThrombosisAnnals of Internal Medicine, 1996
- Venous thromboembolism: Detection by duplex scanningJournal of Vascular Surgery, 1996
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 1995
- Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.Journal of Clinical Investigation, 1993
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993
- Acenocoumarol and Heparin Compared with Acenocoumarol Alone in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1992
- Haemostatic changes that constitute the hypercoagulable stateThe Lancet, 1991
- A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT StudyArchives of internal medicine (1960), 1991
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous ThrombosisNew England Journal of Medicine, 1990
- Tissue Factor and the Initiation of Blood CoagulationPublished by Springer Nature ,1987